APP and Alzheimer disease: KXS improved cognitive function via regulating SIRT3-mediated neuronal cell apoptosis (Su et al., 2023), activating the Wnt/beta-catenin signaling pathway in APP/PS1 mice and AD rats (Shan et al., 2023; Xu et al., 2023).